Umb Bank, N.A. Viatris Inc Transaction History

Umb Bank, N.A.

$6.3 Billion
Q3 2024

A detailed history of Umb Bank, N.A. transactions in Viatris Inc stock. As of the latest transaction made, Umb Bank, N.A. holds 5,236 shares of VTRS stock, worth $65,554. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,236

Previous 4,811 8.83%

Holding current value

$65,554

Previous $51,000 17.65%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$10.32 - $12.13 $4,386 - $5,155	425 Added 8.83%	5,236 $60,000
Q2 2024 Jul 29, 2024	SELL	$10.05 - $12.02 $72,048 - $86,171	-7,169 Reduced 59.84%	4,811 $51,000
Q1 2024 Apr 26, 2024	SELL	$11.27 - $13.53 $16,048 - $19,266	-1,424 Reduced 10.62%	11,980 $143,000
Q4 2023 Jan 23, 2024	SELL	$8.77 - $10.85 $44,332 - $54,846	-5,055 Reduced 27.39%	13,404 $145,000
Q3 2023 Oct 18, 2023	BUY	$9.59 - $11.35 $40,709 - $48,180	4,245 Added 29.86%	18,459 $182,000
Q2 2023 Jul 25, 2023	BUY	$9.02 - $10.29 $31,001 - $35,366	3,437 Added 31.89%	14,214 $141,000
Q1 2023 Apr 11, 2023	BUY	$9.2 - $12.26 $15,888 - $21,173	1,727 Added 19.08%	10,777 $103,000
Q4 2022 Jan 10, 2023	BUY	$8.72 - $11.56 $27,354 - $36,263	3,137 Added 53.05%	9,050 $101,000
Q3 2022 Oct 13, 2022	SELL	$8.48 - $11.13 $17,892 - $23,484	-2,110 Reduced 26.3%	5,913 $51,000
Q2 2022 Jul 20, 2022	SELL	$9.95 - $12.27 $72,903 - $89,902	-7,327 Reduced 47.73%	8,023 $84,000
Q1 2022 Apr 22, 2022	BUY	$9.81 - $15.4 $26,830 - $42,119	2,735 Added 21.68%	15,350 $167,000
Q4 2021 Feb 09, 2022	BUY	$12.09 - $14.68 $152,515 - $185,188	12,615 New	12,615 $170,000

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

933M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.

Account